@LabScheinberg profile picture
The Scheinberg Lab @LabScheinberg

Developing cutting-edge therapeutics for cancer treatment @sloan_kettering. Tweets are from lab members, and not from Dr. Scheinberg, unless signed -DAS

Joined October 2023
  • Tweets 7
  • Following 53
  • Followers 21
3 Photos and videos
Bispecific ➡️ Trispecific Exciting follow up paper from Dr. Tao Dao and Jeremy Meyerberg in @jitcancer. Check it out! jitc.bmj.com/content/14/1/e0…

Trispecific targeting of T cells engineered with TCR mimic antibodies to limit antigen escape

Background Antigen loss and tumor heterogeneity present significant challenges for successful immunotherapies. T-cell receptor (TCR)-based therapies rely on the recognition of epitopes derived from...

jitc.bmj.com
The Scheinberg Lab@LabScheinberg
18 Oct 2024
ICYMI! Check out our paper in @BloodJournal from Dr. Tao Dao on the newly developed ESK2 dual-receptor Ab-TCR platform doi.org/10.1182/blood.202302…
1
21
Congratulations to Dr. Zita Aretz on her incredible thesis defense this past November! Zita, good luck with your postdoctoral research at @UniofOxford
30
We are excited to share our newest publication in @ScienceAdvances authored by @ChemKristen and @PedroCSilberman! Check out our MEAT CARs here: science.org/doi/10.1126/scia…
4
132
Congratulations to Dr. Kristen Vogt on her amazing thesis defense last Friday! @ChemKristen you will be missed!
1
2
82
Congratulations to Dr. Winson Cai on his thesis defense! Check out his recent publication featured in Cancer Immunology Research, “Augmenting CAR T-cell Functions with LIGHT” aacrjournals.org/cancerimmun…
4
62
ICYMI! Check out our paper in @BloodJournal from Dr. Tao Dao on the newly developed ESK2 dual-receptor Ab-TCR platform doi.org/10.1182/blood.202302…

A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and...

A new TCR-mimic monoclonal antibody specific for the WT1-derived epitope RMF presented by HLA-A2, ESK2, was developed.ESK2 was engineered into a new CAR T

ashpublications.org
1
2
4
125
Unfortunately, we have lost access to our past X account. In an effort to regain our following and share some of our newly published research articles, we ask that everyone who visits this page please follow and share our new account. Thank you!
2
108
Load more